New Research Shows MarginProbe® Reduces Re-Excision Rates For Breast Conserving Surgery By 61%, Giving Renewed Hope To Breast Cancer Patients

New Research Shows MarginProbe® Reduces Re-Excision Rates for Breast Conserving Surgery by 61%, Giving Renewed Hope to Breast Cancer Patients

A study recently published in the American Journal of Surgery demonstrates that proper use of Dune Medical Devices’ intraoperative margin assessment device, MarginProbe, results in a significant identification of positive margins and a resulting reduction in the re-excision rate for breast conserving surgery - the standard option for patients with early-stage breast cancer.
Read More

MarginProbe® Reduces the Rate of Re-Excision Following Breast Conserving Surgery for Breast Cancer

Jens-Uwe Blohmer1,2 • Julia Tanko2 • Janina Kueper1 • Jessica Groß1,2 • Ragna Volker1,2 • Anna Machleidt1,2 Anna Machleidt: anna.machleidt@charite.de 1 Breast Center, Charite ́-Universita ̈tsmedizin Berlin, Charite ́platz 1, 10117 Berlin, Germany 2 Department of Gynecology and Breast Center, Sankt-Gertrauden Hospital, Paretzer Str.…

Read More
×